Neurocognitive Dysfunction in Children, Adolescents, and Young Adults With CKD

Rebecca L Ruebner1, Nina Laney1, Ji Young Kim2

  • 1Division of Nephrology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA.

Insights

Children with chronic kidney disease (CKD) show poorer neurocognitive function, especially in attention and memory. Lower estimated glomerular filtration rate (eGFR) and hypertension are linked to these cognitive deficits.

Area of Science:

  • Pediatric Nephrology
  • Neuroscience
  • Clinical Research

Background:

  • Neurocognitive dysfunction is a recognized complication in pediatric chronic kidney disease (CKD).
  • Mechanisms and modifiable risk factors for cognitive impairment in CKD remain underexplored.
  • This study aimed to identify risk factors for cognitive dysfunction in young individuals with CKD.

Purpose of the Study:

  • To characterize neurocognitive function in children, adolescents, and young adults with CKD.
  • To identify risk factors associated with cognitive deficits in this population.
  • To compare neurocognitive performance in CKD patients against healthy controls.

Main Methods:

  • A cross-sectional study design was employed.
  • The Neurocognitive Assessment and Magnetic Resonance Imaging Analysis of Children and Young Adults With Chronic Kidney Disease (NiCK) Study included 90 individuals with CKD and 70 controls, aged 8–25 years.
  • Neurocognitive assessments were analyzed using linear regression, adjusting for estimated glomerular filtration rate (eGFR) and clinical variables; ambulatory blood pressure monitoring was also utilized.

Main Results:

  • Individuals with CKD exhibited significantly poorer performance across multiple neurocognitive domains compared to controls.
  • Deficits were particularly noted in attention, memory, and inhibitory control.
  • Lower eGFR and indicators of hypertension (increased diastolic load, reduced nocturnal dipping) were independently associated with impaired neurocognitive performance.

Conclusions:

  • Reduced eGFR in pediatric CKD patients is linked to diminished neurocognitive performance, affecting attention, memory, and inhibitory control.
  • Hypertension, detected via ambulatory blood pressure monitoring, emerges as a potential risk factor.
  • Neurocognitive function represents a target organ damage in CKD, highlighting the need for monitoring and intervention.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
957
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.2K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
625
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
612
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.4K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
490